Successful Treatment of Life-threatening Bleeding after Cesarean Section with Recombinant Activated Factor VII

Abstract

Hemorrhagic shock developed in a 29-year-old nullipara without coagulopathy after emergency caesarean section. Treatment with uterotonic drugs, prostaglandins, and conservative procedures with transfusion of packed red cells and fresh-frozen plasma failed to control the diffuse vaginal and uterine bleeding. Finally an intravenous bolus injection of 90 μg/kg recombinant activated factor VII (rFVIIa, NovoSeven®, Novo Nordisk A/S, Bagsvaerd, Denmark), was given and showed success within 20 minutes after administration, without any side effects.

Keywords

Postpartum bleeding Emergency cesarean section Recombinant activated factor VII rFVIIa

References

Bouwmeester FW , Jonkhoff AR , Verheijen RHM , van Geijn HP. Successful treatment of life threatening postpartum hemorrhage with recombinant activated factor VII. Obstet Gynecol 2003;101:1174-1174.

Branch DW , Rodgers GM. Recombinant activated factor VII: A new weapon in the fight against hemorrhage. Obstet Gynecol 2003;101:1155-1155.

Breborowicz GH , Sobiewszszyk S , Symankiewicz M. Efficacy of recombinant factor VII (rFVIIa, NovoSeven) in prenatal medicine. Arch Perinat Med 2002;8:21-21.

Bukowski R , Hankins GDV . Managing postpartum hemorrhage. Contemp Obstet Gynecol 2001;9:92-92.

Heuer L , Blumenberg D. Recombinant factor VIIa(Novo-Seven). A review of current and possible future indications. Anaesthesist 2002;51:388-388.

Lisman T , de Groot PHG . Mechanism of action of recombinant factor VIIa. J Thromb Haemost 2003;1:1138-1138.

Moscardo F , Perez F , delaRubia J , et al. Successful treatment of severe intraabdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. Br J Haematol 2001;113:174-174.

Stones RW , Paterson CM , Saunders NJ. Risk-factors for major obstetric haemorrhage. Eur J Reprod Biol 1993;48:15-15.

Zupancic-Salek S , Sokolic V , Viskovic T , et al. Successful use of recombinant factor VIIa for massive bleeding after cesarean section due to HELLP-Syndrome. Acta Haematol 2002;108:162-162.